195 Followers on Owler

Sitka Biopharma

Read more
Kaley Wilson's photo - Interim-CEO of Sitka Biopharma

Interim-CEO

Kaley Wilson

CEO Approval Rating

90/100

Founded:

2013

Status:

PrivateIndependent Company

SITKA BIOPHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Selecta Biosciences is perceived as one of Sitka Biopharma's biggest rivals. Selecta Biosciences's headquarters is in Watertown, Massachusetts, and was founded in 2007. Selecta Biosciences operates in the Biotechnology industry. Selecta Biosciences generates 392% of Sitka Biopharma's revenue.

Blueprint Medicines Corp has been one of Sitka Biopharma's top competitors. Blueprint Medicines Corp is a Public company that was founded in 2011 in Cambridge, Massachusetts. Blueprint Medicines Corp operates in the Pharmaceuticals industry. Compared to Sitka Biopharma, Blueprint Medicines Corp has 411 more employees.

Peloton Therapeutics is Sitka Biopharma's #3 rival. Peloton Therapeutics was founded in Dallas, Texas} in 2010. Peloton Therapeutics is in the Biotechnology industry. Compared to Sitka Biopharma, Peloton Therapeutics generates $1M more revenue.

Sitka Biopharma Acquisitions

No recent acquisitions found related to Sitka Biopharma

Sitka Biopharma Funding History

Since Sitka Biopharma was founded in 2013, it has participated in 4 rounds of funding. In total Sitka Biopharma has raised $5.5M. Sitka Biopharma's last funding round was on Feb 2019 for a total of $1.2M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Feb 2019
$1.2M
Equity
Oct 2018
$1.9M
Seed
Aug 2017
$2.4M

Quark Venture

Seed
Apr 2016
--

Since Sitka Biopharma was founded in 2013, it has participated in 4 rounds of funding. In total Sitka Biopharma has raised $5.5M. Sitka Biopharma's last funding round was on Feb 2019 for a total of $1.2M

Sitka Biopharma Investments

No recent investments found related to Sitka Biopharma

Sitka Biopharma News

Sitka Biopharma Blogs

Social Media

Sitka Biopharma Headquarters

2500 – 1075 West Georgia

Vancouver, British ColumbiaV6E 3C9

Driving Directions »

Trending Companies

Sitka Biopharma Summary

ABOUT

Overview

Sitka Biopharma focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments. Sitka Biopharma was founded in 2013. Sitka Biopharma's headquarters is located in Vancouver, British Colu...

CEO

Sitka Biopharma's Interim-CEO, Kaley Wilson, currently has an approval rating of 90%. Sitka Biopharma's primary competitors are Selecta Biosciences, Blueprint Medicines Corp & Peloton Therapeutics.

Frequently Asked Questions about Sitka Biopharma

  1. When was Sitka Biopharma founded?

    Sitka Biopharma was founded in 2013
  2. Who is Sitka Biopharma's CEO?

    Sitka Biopharma's CEO is Kaley Wilson
  3. How much revenue does Sitka Biopharma generate?

    Sitka Biopharma generates $4M in revenue
  4. How much funding does Sitka Biopharma have?

    Sitka Biopharma has historically raised $5.5M in funding
  1. Where is Sitka Biopharma's headquarters?

    Sitka Biopharma's headquarters is in Vancouver British Columbia, CA
  2. How many employees does Sitka Biopharma have?

    Sitka Biopharma has 18 employees
  3. What sector does Sitka Biopharma operate in?

    Sitka Biopharma is in Biotechnology, Pharmaceuticals
  4. Who are Sitka Biopharma's competitors?

    Sitka Biopharma's top competitors are Selecta Biosciences, Blueprint Medicines Corp, Peloton Therapeutics